Advertisement

Topics

Safety and Therapeutic Drug Monitoring of Cefazolin in Continuous Renal Replacement Therapy

2018-09-19 05:14:16 | BioPortfolio

Published on BioPortfolio: 2018-09-19T05:14:16-0400

Clinical Trials [1983 Associated Clinical Trials listed on BioPortfolio]

Impact of Renal Replacement Therapy on Coagulation Profile of Patients With Acute Renal Failure

Renal failure and high plasmatic level of urea have been associated with an increased risk of hemorrhage in surgical patients. There is only sparse data on the impact of renal replacement ...

Addition of Azithromycin to Cefazolin Will Reduce Post CS Infections More Than Cefazolin Only.

The good standard antibiotic prophylaxis pre elective C S is cefazolin and this study will approve addition of azithromycin to cefazolin will reduce post CS infections more than cefazolin ...

Clearance of Inflammatory Cytokines During Renal Replacement Therapy Using the EMIC®2 Filter

This study will be conducted in patients with sepsis and acute kidney injury needing renal replacement therapy. The aim is to investigate whether continuous renal replacement therapy with...

Pharmacokinetics of Antibiotics in Patients Undergoing Renal Replacement Therapies

The study is aiming to describe the pharmacokinetic and pharmacodynamic profile of intravenous meropenem, ertapenem, cefepime, colistin, Ceftazidime/Avibactam , Ceftolozane/Tazobactam , an...

"Low Flow" CO2 Removal on RRT

The purpose of this study is to test the effectiveness of a membrane gas exchange device in the venovenous circulation of a continuous renal replacement therapy for the purpose of CO2 elim...

PubMed Articles [12202 Associated PubMed Articles listed on BioPortfolio]

Renal Replacement Therapy in the ICU.

The incidence of acute kidney injury in critically ill patients is increasing steeply. Acute kidney injury in this setting is associated with high morbidity and mortality. There is no doubt that renal...

Single- and multiple-dose pharmacokinetics and total removal of colistin in critically ill patients with acute kidney injury undergoing prolonged intermittent renal replacement therapy.

Owing to the emerging problem of MDR bacteria, interest in 'old' antibiotics such as colistin has re-emerged. However, research on the dosing of colistin in patients undergoing renal replacement thera...

Effects of Baseline Thrombocytopenia and Platelet Decrease Following Renal Replacement Therapy Initiation in Patients With Severe Acute Kidney Injury.

Thrombocytopenia is common in critically ill patients with severe acute kidney injury and may be worsened by the use of renal replacement therapy. In this study, we evaluate the effects of renal repla...

Pharmacokinetics of linezolid in critically ill patients on continuous renal replacement therapy: Influence of residual renal function on PK/PD target attainment.

To assess the pharmacokinetics of linezolid in septic patients undergoing continuous renal replacement therapy (CRRT) and investigate whether residual renal function affects the probability of attaini...

Analysis of emergency Department Frequentation among patients with advanced CKD (chronic kidney disease): Lessons to optimise scheduled renal replacement therapy initiation.

The decision to initiate renal replacement therapy (RRT) implies a wide margin of uncertainty. Glomerular filtration rate (GFR) tells us the magnitude of renal damage. Proteinuria indicates the speed ...

Medical and Biotech [MESH] Definitions

Procedures which temporarily or permanently remedy insufficient cleansing of body fluids by the kidneys.

Therapeutic replacement or supplementation of defective or missing enzymes to alleviate the effects of the enzyme deficiency (e.g., GLUCOSYLCERAMIDASE replacement for GAUCHER DISEASE).

The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.

The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.

Therapeutic use of hormones to alleviate the effects of hormone deficiency.

More From BioPortfolio on "Safety and Therapeutic Drug Monitoring of Cefazolin in Continuous Renal Replacement Therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial